Annovis Bio Receives Japanese Patent for the Treatment of Acute Brain or Nerve Injury
Berwyn, Pennsylvania–(Newsfile Corp. – March 10, 2021) – Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing
Read moreBerwyn, Pennsylvania–(Newsfile Corp. – March 10, 2021) – Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing
Read moreCHEYENNE, WY / ACCESSWIRE / February 24, 2021 / MJ Biotech, Inc. (OTC PINK:MJTV), is pleased to report that Sterile
Read moreXenetic Biosciences, Inc. Announces Partner’s Filing of Registration Dossier in Russia for Epolong Product Candidate That Utilizes Xenetic’s PolyXen(R) Platform
Read moreFansUnite Signs Engagement Letter with Gaming Law Firm to Pursue U.S. Licensing Strategy Ifrah Law will guide FansUnite in navigating
Read more